Thus, in future studies, we can provide a scholarly examination of the clinical prediction and prognosis of AKI by conducting a prospective study that includes not only the CPK time course but also data on plasma creatinine time course, serum myoglobin, urine myoglobin, CPK half-life, and other relevant tests over time. The gene discussed is PIK3C2A; the disease is acute kidney injury.